Item 8.01 Other Events.

On December 9, 2020, Greenwich LifeSciences, Inc. (the "Company") announced the publication of a poster for the GP2 Phase IIb clinical trial final efficacy analysis at the San Antonio Breast Cancer Symposium in a virtual format. A copy of the press release is attached hereto as Exhibit 99.1and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.




Exhibit No.                 Description

99.1            Press release dated December 9, 2020




  -2-

© Edgar Online, source Glimpses